Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Graham G Russell

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
BMJ (Clinical Research Ed.)|March 14, 2013
Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpretedBo Abrahamsen, Michael Pazianas, R Graham G Russell
Bone|December 15, 2010
Denosumab and bisphosphonates: different mechanisms of action and effectsRoland Baron, Serge Ferrari, R Graham G Russell
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2008
Osteonecrosis of the jaw: more heat than lightMichael Pazianas, R Graham G Russell, Ignac Fogelman
Current Opinion in Rheumatology|June 1, 2006
Bone biology and the pathogenesis of osteoporosisR Graham G Russell, Belen Espina, Philippa Hulley
Current Opinion in Pharmacology|April 11, 2016
Pyrophosphate: a key inhibitor of mineralisationIsabel R Orriss, Timothy R Arnett, R Graham G Russell
Therapeutics and Clinical Risk Management|November 9, 2013
Eliminating the need for fasting with oral administration of bisphosphonatesMichael Pazianas, Bo Abrahamsen, Serge Ferrari, et al.
Therapeutics and Clinical Risk Management|June 22, 2011
If you don't take it - it can't work: the consequences of not being treated or nonadherence to osteoporosis therapyJonathan D Adachi, Robert G Josse, R Graham G Russell
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2007
Herbert Andre Fleisch, MDT John Martin, Jean-Philippe Bonjour, R Graham G Russell
Therapeutics and Clinical Risk Management|July 30, 2010
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosisMichael Pazianas, Cyrus Cooper, F Hal Ebetino, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 25, 2011
Esophageal and gastric cancer incidence and mortality in alendronate usersBo Abrahamsen, Michael Pazianas, Pia Eiken, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
BMJ (Clinical Research Ed.)|March 14, 2013
Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpretedBo Abrahamsen, Michael Pazianas, R Graham G Russell
Bone|December 15, 2010
Denosumab and bisphosphonates: different mechanisms of action and effectsRoland Baron, Serge Ferrari, R Graham G Russell
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2008
Osteonecrosis of the jaw: more heat than lightMichael Pazianas, R Graham G Russell, Ignac Fogelman
Current Opinion in Rheumatology|June 1, 2006
Bone biology and the pathogenesis of osteoporosisR Graham G Russell, Belen Espina, Philippa Hulley
Current Opinion in Pharmacology|April 11, 2016
Pyrophosphate: a key inhibitor of mineralisationIsabel R Orriss, Timothy R Arnett, R Graham G Russell
Therapeutics and Clinical Risk Management|November 9, 2013
Eliminating the need for fasting with oral administration of bisphosphonatesMichael Pazianas, Bo Abrahamsen, Serge Ferrari, et al.
Therapeutics and Clinical Risk Management|June 22, 2011
If you don't take it - it can't work: the consequences of not being treated or nonadherence to osteoporosis therapyJonathan D Adachi, Robert G Josse, R Graham G Russell
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2007
Herbert Andre Fleisch, MDT John Martin, Jean-Philippe Bonjour, R Graham G Russell
Therapeutics and Clinical Risk Management|July 30, 2010
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosisMichael Pazianas, Cyrus Cooper, F Hal Ebetino, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 25, 2011
Esophageal and gastric cancer incidence and mortality in alendronate usersBo Abrahamsen, Michael Pazianas, Pia Eiken, et al.
Pageof 7